Bringing Together
Global Leaders of the
Generics and Biosimilars Industry

FEBRUARY 13-16, 2023 | JW MARRIOTT ORLANDO BONNET CREEK RESORT & SPA, ORLANDO, FLORIDA

ACCESS 2023!
FEBRUARY 13-15, 2023
#ACCESS2023

25th IGBA Annual Conference
FEBRUARY 15-16, 2023
#IGBA2023

access!™ 2023 – aam annual meeting

AAM’s annual meeting Access! 2023 is where policymakers, influential speakers and industry leaders come together to collaborate, exchange ideas and chart the future of generics and biosimilars. You’ll hear firsthand from world-renowned speakers and learn about the critical business, breakthroughs and politics shaping our industry.

THE PATH AHEAD

What is the state of our industry? What’s on the horizon? Meet the leaders and decision-makers who impact the future of generics and biosimilars. Take advantage of this unique, annual opportunity to network with industry colleagues and get inspired by new experiences, real talk and fresh ideas. Join attendees and exhibitors at Access! 2023! Follow updates on Twitter with #Access2023.

TWO CONFERENCES – ONE LOCATION

And, if you are interested in learning more about the most pressing policy questions influencing patient access to generic and biosimilar medicines in countries around the world, make sure to stay and attend IGBA’s 25th Annual Conference, which will take place February 15-16 at the same hotel

25th IGBA Annual Conference

Join your colleagues from around the world to network and discuss challenges and opportunities for the global generics and biosimilars industries. For the first time since 2014, IGBA’s Annual Conference will be held in the United States, in conjunction to with AAM’s Access! 2023 Annual Meeting. This event will offer a unique opportunity to hear from leading global stakeholders, industry leaders and other experts offering their views and analysis of the most pressing policy questions influencing patient access to generic and biosimilar medicines in countries around the world.

NETWORKING
OPPORTUNITIES

Build more connections by attending both events which offers a full schedule of professional networking opportunities and social events. Whether you’re looking to advance your career or learn informally from an industry leader, this is your chance to strike up that pivotal conversation. Meet up with old colleagues or potential collaborators.

Access! 2021

Why You Should Attend

Hear insights on the latest global trends affecting your company and your future

Understand the interconnection between the U.S. and global markets

Gain access to breakthrough information about generics and biosimilars

Explore the latest developments in the generics and biosimilars industry

Interact with leaders in the industry

Experience a one-of-a-kind networking opportunity with industry peers

EXPO
OPPORTUNITIES

Showcase your company at two conferences! Don’t miss out on this highly-interactive, top-notch business environment which allows industry vendors to meet with generics and biosimilars industry executives. we offer out exhibitors abundant networking time with industry decision-makers. Reserve your space today!
Space is limited

 

SHOWCASE YOUR COMPANY AT ACCESS! 2023

SPONSORSHIP OPPORTUNITIES

Raise your company profile by participating in this prestigious event. Included in your sponsorship are custom branded digital assets you can use to promote your sponsorship of the event. You will also gain visibility to your brand through conference advertising prior to and during the event. For more information regarding sponsorship levels and benefits contact Jennifer Soup.

Publication Partners

EXPERIENCE ORLANDO!

No destination delivers exciting, unforgettable experiences like Orlando. We encourage you to spend some time exploring the city during your visit. Click here to purchase discounted attractions tickets, trip-planning advice, dining and entertainment options, and more.

Access-2023-patient-group-2

Download Coming Soon

GET THE LASTEST UPDATES

Receive the latest event information about key speakers, sponsorship opportunities and exhibiting.

Recent Tweets

ICYMI, in @WSJ recent article “World’s Top-Selling Drug Going Off Patent Means Big Bucks for Middlemen,” @david_wainer notes how PBMs stand to benefit from #biosimlar competition.

Read more here: https://www.wsj.com/articles/worlds-top-selling-drug-going-off-patent-means-big-bucks-for-middlemen-11669478041

Load More...
Skip to content